{"denomUnitsSelected":"Participants","description":"-Overall survival (OS) will be defined as time from ASCT to death due to any causes. Patients who are alive at the time of data analyses will be censored on the last known alive date. Patients who are removed from study therapy prior death will be censored at the time of initiation of subsequent anti-myeloma treatment.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 5 years post completion of treatment","title":"Overall Survival (OS)","type":"SECONDARY"}